Professional Documents
Culture Documents
net/publication/334784456
CITATIONS READS
5 845
1 author:
Sayani Bhattacharyya
Krupanidhi College of Pharmacy
8 PUBLICATIONS 16 CITATIONS
SEE PROFILE
All content following this page was uploaded by Sayani Bhattacharyya on 31 July 2019.
1. The Oxford College of Pharmacy, 6/9 Ist cross Begur Road, Hongasandra, Bangalore 560068, India
[Email: sayanibh@hotmail.com, Tel: 447404237669]
2. The Oxford College of Pharmacy, 6/9 Ist cross Begur Road, Hongasandra, Bangalore 560068, India.
[Email: swethareddy555@gmail.com, Tel: 918030219831]
The present work is based on the formulation of effervescent granules of Fexofenadine hydrochloride unit dose.
Eight such formulations were prepared using different acids, salts, diluents and superdisintegrants by the wet
granulation method. The prepared granules were evaluated for flow property (like angle of repose, bulk density,
tapped density and Hausner’s ratio), particle size, moisture content, Effervescence time, in vitro dissolution studies
and stability studies. The formulated effervescent granules exhibited excellent flow properties and bulk density
suitable for a unit dose. The low moisture content of the formulations supported the stability of the formulations. All
the formulations exhibited effervescence time less than 20 sec and dissolution profile was found to be more than
95% in 5 mins. The stability studies revealed that the product was stable at variable temp and humidity conditions.
Keyword:
Vol. 3 No. 3. 2014 www.thepharmajournal.com Page | 1
The Pharma Innovation - Journal
Vol. 3 No. 3 2014 www.thepharmajournal.com Page | 2
The Pharma Innovation - Journal
Vol. 3 No. 3. 2014 www.thepharmajournal.com Page | 3
The Pharma Innovation - Journal
3.8.1 Statistical analysis filter paper and diluted with phosphate buffer to
The difference in the release data for the different analyze in the UV spectrophotometer. The
formulation was done by one way analysis of absorbance was noted; the cumulative % release
variance of means (ANOVA)at the 5% was calculated.
significance level using Microsoft 2007 excel
package. In vitro disintegration time was taken as 4. Stability studies
the parameter for ANOVA analysis. To assess the drug and formulation stability,
stability studies were done according to ICH
3.9 Dissolution studies guidelines. All the formulations were tested for
The in vitro dissolution studies were carried out Short term testing for a period of 1st month at
in the USP dissolution test apparatus (Electro lab 25±2 °C/ 60±5% RH and Accelerated testing for
TDT – 08 L Dissolution testers USP) type 2 a period of 2nd month at 40±2 °C/ 75±5% RH,
(paddle) [12]. A 900 ml of the dissolution medium for their moisture content, drug content and
(phosphate buffer pH 6.8) was taken in a covered effervescence time [13].
vessel and the temperature was maintained at 37±
0.5 ºC. The speed of the paddle was set at 50 rpm. 5. Results and discussion
Sampling was done at every one minute interval. 5.1 Particle size analysis
For each sample one ml of the dissolution The particle size analysis showed maximum
medium was withdrawn and the same amount of retention was in the size range 355-500 µm for all
dissolution medium at 37±0.5 ºC was replenished the formulations as shown in Fig 1. The mean
to the dissolution medium. The sample diameter of the granules was found to be 0.4 mm
withdrawn was filtered with Whatman approximately.
Vol. 3 No. 3 2014 www.thepharmajournal.com Page | 4
The Pharma Innovation - Journal
Vol. 3 No. 3. 2014 www.thepharmajournal.com Page | 5
The Pharma Innovation - Journal
and disintegration time as parameter yielded a P- formulations were found to be different (P-value
value 1.34E-10, so it can be concluded all the <0.001).
Vol. 3 No. 3 2014 www.thepharmajournal.com Page | 6
The Pharma Innovation - Journal
Fig 4: Drug content analysis after stability study for all formulations
Vol. 3 No. 3. 2014 www.thepharmajournal.com Page | 7
The Pharma Innovation - Journal
Vol. 3 No. 3 2014 www.thepharmajournal.com Page | 8